The Genetic Basis of Hypertriglyceridemia

Area of Science:

• Genetics
• Cardiovascular Medicine
• Metabolic Disorders

Background:

• Hypertriglyceridemia is a prevalent dyslipidemia linked to cardiovascular disease and pancreatitis.
• While severe cases can be monogenic, most hypertriglyceridemia results from combined genetic, lifestyle, and environmental factors.
• Understanding the genetic architecture is crucial for effective management.

Purpose of the Study:

• To review recent advancements in understanding the genetic basis of hypertriglyceridemia.
• To highlight the role of polygenic inheritance in hypertriglyceridemia phenotypes.
• To explore the translational implications of genetic discoveries for treatment and screening.

Main Methods:

• Genome-wide association studies (GWAS) to identify genetic loci associated with triglyceride levels.
• Analysis of polygenic scores to assess the contribution of multiple genetic variants.
• Review of current literature on genetic discoveries and their clinical relevance.

Main Results:

• Over 300 genetic loci linked to triglyceride levels have been identified through large-scale GWAS.
• Polygenic scores reveal that many hypertriglyceridemia cases have a polygenic, not solely monogenic, basis.
• New genetic insights enhance the understanding of triglyceride regulation and dyslipidemia.

Conclusions:

• Genetic discoveries are transforming the understanding of hypertriglyceridemia.
• These findings pave the way for novel triglyceride-lowering therapies and personalized genetic screening.
• Translational opportunities include developing targeted treatments based on an individual's genetic profile.